These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33663099)

  • 21. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
    Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
    Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
    Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
    Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.
    Choi HS; Park DI; Hwang SJ; Park JS; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Helicobacter; 2007 Dec; 12(6):638-42. PubMed ID: 18001407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    Park CH; Kim EH; Roh YH; Kim HY; Lee SK
    PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ; Salas M; Ward A
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis.
    Li MJ; Li Q; Sun M; Liu LQ
    Medicine (Baltimore); 2017 Sep; 96(39):e8120. PubMed ID: 28953640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
    Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of acupuncture on relieving abdominal pain and distension for acute pancreatitis: A protocol for systematic review.
    Zhu X; Yang L; Li X; Zhu F; Li Z; Craemer A; Xiong Y; Lan Y; Zhao Y; Wu J
    Medicine (Baltimore); 2020 Feb; 99(8):e19044. PubMed ID: 32080079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
    Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.
    Foroutan N; Fahimi F; Dabiri Y; Foroutan A; Habibi M; Salamzadeh J
    J Popul Ther Clin Pharmacol; 2015 Dec; 22(3):e292-e302. PubMed ID: 28414416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of traditional Chinese herbal formula combined with western medicine for gastroesophageal reflux disease: A protocol for systematic review and meta-analysis.
    Lin W; Huang G; Liu X; Lin H; Zhou H; Feng C; Wang T; Liang R
    Medicine (Baltimore); 2020 Oct; 99(41):e22454. PubMed ID: 33031277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neostigmine for the treatment of acute pancreatitis: a protocol for a systematic review and meta-analysis.
    He K; Yan X; Yang Z; Zhang Y; Shu H; Wu D
    BMJ Open; 2023 Mar; 13(3):e070289. PubMed ID: 36958784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.
    Villoria A; Garcia P; Calvet X; Gisbert JP; Vergara M
    Aliment Pharmacol Ther; 2008 Oct; 28(7):868-77. PubMed ID: 18644011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
    Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.